TDSGF Stock - Telo Genomics Corp.
Unlock GoAI Insights for TDSGF
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Free 14-day trial • No credit card required
Premium members get real-time SMS alerts
Financial Statements
| Metric | FY2025 | FY2024 | FY2023 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | $-10,614 | N/A | $-33,114 | $-62,228 | $-64,719 |
| Gross Margin | N/A | N/A | N/A | N/A | N/A |
| Operating Income | $-2,702,382 | $-2,801,580 | $-2,815,566 | $-1,073,713 | $-1,215,161 |
| Net Income | $-2,718,753 | $-2,713,010 | $-2,820,772 | $-1,069,963 | $-1,241,696 |
| Net Margin | N/A | N/A | N/A | N/A | N/A |
| EPS | $-0.02 | $-0.04 | $-0.05 | $-0.02 | $-0.03 |
Telo Genomics Corp., a biotech company, engages in the development and commercialization of predictive technological products to personalize treatment plans for patients with specific conditions. It provides telomere analysis platform with diagnostic and prognostic applications; and solutions with liquid biopsies and related technologies in oncology and neurological diseases. The company's lead application is Telo-MM, a solution that provides actionable information to medical professionals in the treatment of Multiple Myeloma, a form of blood cancer. Its solutions also include TeloView, a proprietary software platform used to quantify specific features of each patient's telomeres. The company serves pathologists, clinicians, academic researchers, and drug developers. Telo Genomics Corp. has a collaboration agreement with the Mayo Clinic to validate its Telo-MM tests for multiple myeloma. The company was formerly known as 3D Signatures Inc. and changed its name to Telo Genomics Corp. in April 2019. Telo Genomics Corp. was incorporated in 2014 and is headquartered in Toronto, Canada.
Visit WebsiteEarnings History & Surprises
TDSGFEPS Surprise History
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2026 | May 25, 2026 | — | — | — | — |
Q1 2026 | Feb 25, 2026 | — | — | — | — |
Q4 2025 | Nov 27, 2025 | — | $-0.00 | — | — |
Q2 2025 | May 26, 2025 | — | $-0.01 | — | — |
Q1 2025 | Feb 25, 2025 | — | $-0.01 | — | — |
Q4 2024 | Nov 20, 2024 | — | $-0.01 | — | — |
Q2 2024 | May 30, 2024 | — | $-0.01 | — | — |
Q2 2024 | May 28, 2024 | — | $-0.01 | — | — |
Q1 2024 | Feb 27, 2024 | — | $-0.01 | — | — |
Q4 2023 | Nov 22, 2023 | — | $-0.01 | — | — |
Q2 2023 | Jun 1, 2023 | — | $-0.01 | — | — |
Q2 2023 | May 18, 2023 | — | $-0.01 | — | — |
Q1 2023 | Feb 28, 2023 | — | $-0.01 | — | — |
Q4 2022 | Nov 17, 2022 | — | $-0.01 | — | — |
Q2 2022 | Jun 30, 2022 | — | $-0.01 | — | — |
Q2 2022 | May 20, 2022 | — | $-0.01 | — | — |
Q1 2022 | Feb 28, 2022 | — | $-0.01 | — | — |
Q3 2021 | Sep 30, 2021 | — | $-0.01 | — | — |
Q2 2021 | Jun 30, 2021 | — | $-0.01 | — | — |
Q1 2021 | Mar 31, 2021 | — | $-0.00 | — | — |
Latest News
Frequently Asked Questions about TDSGF
What is TDSGF's current stock price?
What is the analyst price target for TDSGF?
What sector is Telo Genomics Corp. in?
What is TDSGF's market cap?
Does TDSGF pay dividends?
Similar Stocks
Healthcare SectorExplore stocks similar to TDSGF for comparison